Editorial Board
79 Editors in 15 Countries/Region
Editor-in-Chief
Godefridus J. Peters 
gj.peters@amsterdamumc.nl Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (Amsterdam UMC), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Research Interests: cancer biomarkers, apoptosis, lung diseases, cell culture, gene expression, pharmacokinetics, pharmacodynamics and pharmacogenetics of anticancer drugs, gastrointestinal cancers, translational research, animal models, drug metabolism and transport, influx and efflux proteins.
Associate Editors
Yehuda G. Assaraf
Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Research Interests: molecular mechanisms of anticancer drug resistance, drug discovery, physiology.
Wafik S. El-Deiry
Legorreta Cancer Center, Brown University, Providence, RI, USA.
Research Interests: autophagy, p53 tumor suppression, cell death signaling pathways, DNA damage, TRAIL pathway, hypoxia, drug resistance, novel therapeutics, translational oncology.
Liwu Fu
State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Research Interests: ABC transporter, cancer therapy, chemotherapy resistance, multidrug resistance, immune checkpoint blockade, leukemia.
Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response
Editorial Board Members
Aamir Ahmad
Dermatology Institute and Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Research Interests: non-coding RNAs expression, signaling in cancer metastasis, circulating and tissue biomarkers.
Suresh V. Ambudkar
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Research Interests: ATP-binding cassette (ABC) drug transporters, drug resistance, membrane biochemistry, chemoresistance, transport proteins.
Asfar Sohail Azmi
Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Research Interests: cancer therapy, drug resistance, nanotechnology, theranostics, biomarker.
Maria R. Baer
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Research Interests: acute myeloid leukemia, FLT3 internal tandem duplication, signaling pathways, kinase inhibitors, drug resistance.
Benjamin Bonavida
Department of Microbiology, Immunology and Molecular Genetics, Johnsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA, USA.
Research Interests: apoptosis, immunotherapy resistance, cancer drug resistance.
Stergios Boussios
Faculty of Life Sciences and Medicine, King's College London, London, UK.
Research Interests: cancer treatment, cancer in pregnancy, cancer diagnostics, cancer biology, cancer biomarkers, gynaecological cancers, urological cancers, colorectal cancer, autoimmunity.
Ingolf Cascorbi
Institute of Experimental and Clinical Pharmacology, Kiel University, Kiel, Germany.
Research Interests: cancer biology, pharmacokinetics, genotyping, mutation, DNA, genetics, enzymes, drug safety, pharmaceutical development, intensive care medicine.
Claudio Cerchione
Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Research Interests: myelodysplastic syndromes, hematological malignancies, lymphoma, multiple myeloma, hematologic diseases, clinical hematology, blood disorders, acute myeloid leukemia, chemotherapy, leukemia, acute lymphoblastic leukemia.
Wei Chen
Department of Physics, The University of Texas at Arlington, Arlington, TX, USA.
Research Interests: nanomedicine, cancer nanotechnology, drug delivery, targeting, hypoxia, cancer resistance, radiotherapy, photodynamic therapy, photothermal therapy, chemodynamic therapy.
Zhesheng Chen
Department of Pharmaceutical Sciences, St. John’s University, Queens, NY, USA.
Research Interests: ABC transporters, multidrug resistance, cancer pharmacology.
William C. Cho
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.
Research Interests: cancer biomarkers, drug repurposing, non-coding RNA, proteomics.
Mario Cioce
Laboratory of Molecular Medicine and Biotechnology, University Campus Bio-Medico of Rome, Rome, Italy.
Research Interests: mesothelioma, metformin, CSC, translational oncology, chemoresistance, TKI, Ephrin, EMT.
Jacqueline Cloos
Department of Hematology, VU University Medical Center, Amsterdam, Netherlands.
Research Interests: proteasome inhibitors, minimal residual disease, clonal evolution, splicing, cellular drug addiction, hematology, drug combination studies.
Paul Dent
Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA.
Research Interests: cancer therapeutics, rational combination of drugs, molecular mechanisms, drug combinations synergize, breast, brain, liver and pancreatic cancers.
Changming Dong
School of Chemistry & Chemical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Research Interests: biodegradable polymer nanomedicine, cancer combination therapy, drug delivery systems, multidrug resistance.
Thomas Efferth
Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany.
Research Interests: natural product chemistry, medicinal and pharmaceutical chemistry, virtual drug screening, transcriptomics, network pharmacology, biochemistry, drug development, apoptosis, cancer biology.
Marco Falasca
Curtin Health Innovation Research Institute, Curtin University, Perth, Australia.
Research Interests: pancreatic cancer, exosomes, lipid metabolism, membrane transporters, signal transduction, cancer invasion and metastasis, phosphoinositide signalling, cannabinoids.
David Gewirtz
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Research Interests: autophagy, senescence, cancer chemotherapy, chemosensitization, radiosensitization, chemtoxicity.
Jean-Pierre Gillet
Laboratory of Molecular Cancer Biology, Faculty of Medicine, University of Namur, Namur, Belgium.
Research Interests: ATP-binding cassette transporters, cancer multidrug resistance mechanisms, pharmacogenomics, cancer biology, transcriptomics.
Antonio Giordano
Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, USA; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Research Interests: cancer, cell cycle, pRB2/p130, CDK9, pathology, genetics.
Elisa Giovannetti
Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers (Amsterdam UMC), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Pharmacology Lab, Fondazione Pisana per la Scienza, Pisa, Italy.
Research Interests: molecular pharmacology, chemoresistance, pancreatic cancer, thoracic cancers.
William Gmeiner
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Research Interests: colorectal cancer, fluoropyrimidine, thymidylate synthase, DNA topoisomerase, aberrant signaling pathways in tumor cells.
Entrapment of DNA topoisomerase-DNA complexes by nucleotide/nucleoside analogs
Targeting DNA topoisomerases: past & future
Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutations
Michael M Gottesman
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Research Interests: cancer therapy, drug resistance, nanotechnology, theranostics, biomarker.
Sanjay Gupta
Department of Urologic Oncology, Case Western Reserve University, Cleveland, OH, USA.
Research Interests: cancer chemoprevention, cancer therapeutics, drug resistance, drug repurposing, translational oncology, cancer biology, signal transduction, apoptosis, antioxidant activity, artificial intelligence, cancer biomarkers, diet nutrition and cancer, drug delivery, toxicology, epigenetics, inflammation, cancer stem cells.
Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
Dietary phytochemicals and their role in cancer chemoprevention
Role of prostate cancer stem-like cells in the development of antiandrogen resistance
New insights for drug resistance in metastatic castration-resistant prostate cancer
Georg Hempel
Department of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, University of Muenster, Muenster, Germany.
Research Interests: capillary electrophoresis, chromatography, pharmacokinetics, drug safety, oncology.
Dominique Heymann
Institut de Cancérologie de l'Ouest, Tumour Heterogeneity and Precison Medicine Laboratory, Saint-Herblain, France.
Research Interests: circulating tumour cells, pathogenesis of bone sarcoma, osteoclast differentiation, metastatic process.
Peter J. Houghton
Greehey Children’s Cancer Research Institute, University of Texas Health Science Center, San Antonio, TX, USA.
Research Interests: pediatric sarcomas, low-grade brain tumors, pediatric cancers of the kidney, nephroblastoma.
Zhiqing Huang
Department of Obstetrics and Gynecology, Division of Reproductive Sciences, Duke University Medical Center, Durham, NC, USA.
Research Interests: ovarian cancer, cancer chemoresistance, tumor microenvironment, epigenetics and epigenomics.
Thomas Hutson
Baylor Sammons Cancer Center, Texas Oncology, Dallas, TX, USA.
Research Interests: renal cell carcinoma, bladder cancer, prostate cancer, testicular cancer, immunotherapy.
Marja Jäättelä
Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Copenhagen, Denmark.
Research Interests: autophagy, cancer progression, lysosomal, DNA, pH regulation.
Gerrit Jansen
Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands.
Research Interests: rheumatology, cancer biology and immunology, imaging and biomarkers, inflammatory diseases, antifolates, proteasome inhibitors, (multi) drug resistance.
Markus Joerger
Division of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Research Interests: thoracic malignancies, clinical pharmacology, pharmacogenetics, pharmacokinetics, immunotherapy.
Alan Prem Kumar
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Lower Kent Ridge, Singapore.
Research Interests: female reproductive cancers, drug development, cancer biomarker discovery, cancer signaling, cancer target identification, cancer driver mutations, cancer immunology.
Hang Fai Kwok
Faculty of Health Sciences, University of Macau, Macau, China.
Research Interests: novel therapeutic antibodies development, venom-based peptide & natural biomolecule prototype drugs development, cancer biomarkers & immunotherapy markers discovery for prognostic and therapeutic validation.
Natasha Kyprianou
Department of Pathology and Molecular & Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Research Interests: prostate cancer, bladder cancer, kidney cancer, cancer therapeutics, drug resistance, apoptosis, EMT.
Jonathan A. Ledermann
Cancer Institute, University College London, London, UK.
Research Interests: gynaecological cancers, ovarian cancer.
Saverio Marchi
Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy.
Research Interests: cell signaling, cancer biology, cell death, molecular cell biology, mitochondria, calcium.
Giovanni Martinelli
Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Research Interests: leukemia, myelodysplastic syndromes, multiple myeloma, hematologic diseases, lymphoma, blood disorders, stem cell transplantation, chemotherapy, clinical hematology, hematology.
Cornelis J. M. Melief
Department of Immunohematology and Bloodtransfusion, Leiden University Medical Center, Leiden, the Netherlands.
Research Interests: HLA (human leukocyte antigen), MHC, histocompatibility, immunotherapy, cancer research, clinical immunology, cancer vaccines.
Martin Michaelis
School of Biosciences, University of Kent, Canterbury, UK.
Research Interests: virology, emerging infectious diseases, apoptosis, virus, PCR, cancer cell line.
Enrico Mini
Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
Research Interests: leukemia, antimetabolites and metal-based drug resistance, gastrointestinal cancers, cancer pharmacogenomics, pharmacogenetics.
Priyabrata Mukherjee
Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Research Interests: programming tumor microenvironment by nanoparticles, anti-angiogenic property of inorganic nanoparticles, metabolic enzyme and angiogenesis, identification of new molecular targets using nanotechnology, nanoendocytosis, understanding cellular processes using engineered nanoparticles, metabolic enzymes in cancer.
Natarajan Muthusamy
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.
Research Interests: immunology, leukemia, lymphoma, B lymphocytes, targeted therapeutics.
Patrycja Nowak-Sliwinska
School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland; Translational Research Center in Oncohaematology, University of Geneva, Geneva, Switzerland.
Research Interests: multi drug combinations, drug-drug interactions, acquired drug resistance, cancer organoids, cancer treatment, tumor angiogenesis, targeted therapies.
Gianpaolo Papaccio
Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Research Interests: cancer stem cells, peritumoral tissue, mitochondrial transfer, organoids, adipose stem cells and cancer, hyaluronans and cancer.
Paola Perego
Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Research Interests: molecular biology, p53, DNA damage, apoptosis, cytotoxicity, pharmacology, cancer cell line.
Francesco Pezzella
Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Research Interests: cancer, blood vessels, vessel co-option, non-angiogenic tumours, angiogenesis, pathology.
Roger M. Phillips
Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
Research Interests: tumour hypoxia, cancer metabolism, hypoxia activated prodrugs, drug discovery (including phenotypic drug evaluation), drug delivery to the tumour microenvironment.
Raphael E. Pollock
Department of Surgery, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Research Interests: sarcoma, neoplasms, neurilemmoma, gastrointestinal stromal tumors, breast neoplasms, leiomyosarcoma, neoplasm metastasis, ewing, liposarcoma, myxoid, liposarcoma.
Paolo Ettore Porporato
Department of Molecular Biotechnology and Health Science, Molecular Biotechnology Center, University of Turin, Turin, Italy.
Research Interests: cancer metabolism, muscle atrophy, mitochondrial ROS, cachexia, iron.
Chiara Riganti
Department of Oncology, University of Torino, Torino, Italy.
Research Interests: chemo-immunoresistant tumor models, lung cancer, prostate cancer, breast cancer, malignant pleural mesothelioma, glioblastoma multiforme, multiple myeloma.
Robert W. Robey
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Research Interests: cancer drug resistance, ATP-binding cassette transporters, ABCG2, histone deacetylase inhibitors, METTL7A.
José Rueff
Center for Toxicogenomics and Human Health (ToxOmics), NOVA Medical School-FCM, Universidade Nova de Lisboa, Lisbon, Portugal.
Research Interests: genetics, bacterial cell culture, immunohistochemistry, biochemistry, genomics, PCR, gene expression, cell culture, DNA, cancer biology.
Ahmad R Safa
Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.
Research Interests: cancer drug resistance, cancer stem cells, apoptosis resistance, anti-apoptotic roteins, pro-apoptotic proteins.
John D. Schuetz
Department of Pharmacy and Pharmaceutical Science, St. Jude Children's Research Hospital, Memphis, TN, USA.
Research Interests: role of ABC transporters in response to chemotherapy, biological function of ABC transporters, regulation of ABC transporters.
Gautam Sethi
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Kent Ridge, Singapore.
Research Interests: cancer, cellular and molecular mechanisms, diagnostics and therapeutics, gastrointestinal cancer.
John Seymour
Peter MacCallum Cancer Centre, Royal Melbourne Hospital & University of Melbourne, Victoria, Australia.
Research Interests: haematology, aggressive lymphoma, acute leukemia, myelodysplasia.
Xiangyang Shi
State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Chemistry, Donghua University, Shanghai, China.
Research Interests: development of organic/inorganic hybrid nanoplatforms and microfluidic platforms for sensing, precision cancer imaging and therapy.
Alexander Sparreboom
Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
Research Interests: platinum-based drugs, tyrosine-kinase inhibitors, P-glycoprotein, cancer chemotherapy, sensitivity analysis, clinical pharmacokinetics.
Rakesh Srivastava
Stanley S. Scott Cancer Center, School of Medicine, Louisiana State University Health-New Orleans, New Orleans, LA, USA.
Research Interests: apoptosis, cell signaling and human diseases, molecular mechanisms, stem cells and human diseases, nutrition, diet and cancer.
Gary S. Stein
Department of Biochemistry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Research Interests: breast cancer stem cells, genetic and epigenetic of cancer.
Ulrike Stein
Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Research Interests: key drivers of metastasis, MACC1, S100A4, cancer cell signaling, cancer metastasis, drug discovery.
Chunxia Su
Department of Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Research Interests: non-small cell lung cancer, lung cancer, tumor microenvironment, immunotherapy.
Haruhiko Sugimura
Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Research Interests: cancer biology, genetics, genotyping, cell biology, microscopy, hepatocellular carcinoma, pharmacology, immunohistochemistry, DNA, mutation.
Dean G Tang
Professor & Chairman, Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Research Interests: cancer stem cells, prostate cancer, stem cells, cancer cell heterogeneity, lineage plasticity, therapy resistance, cancer vaccine.
Hailin Tang
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Research Interests: cancer, metastasis, metabolism, animal model, non-coding RNA.
Kenneth Kin Wah To
School of Pharmacy, the Chinese University of Hong Kong, Hong Kong, China.
Research Interests: multidrug resistance in cancer chemotherapy, drug repurposing, cancer epigenetics.
Vladimir P. Torchilin
Center of Pharmaceutical Biotechnology and Nanomedicines, Department of Chemical Engineering, Northeastern University Boston, Boston, MA, USA.
Research Interests: drug delivery, drug targeting, nanomedicine, liposomes, micelles, experimental cancer therapy.
Brian A. Van Tine
Department of Medicine, Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA.
Research Interests: soft tissue and bone sarcomas, human-in-mouse sarcoma models, amino acid deprivation therapies, metabolic deficiencies in sarcoma, phase 1 clinical trials.
Robert C.A.M. van Waardenburg
Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA.
Research Interests: DNA repair proteins, cellular response to chemotherapy, protein-protein interactions, post-translational modification by ubiquitin and SUMO, sulfotransferases.
Erik A. C. Wiemer
Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Research Interests: cancer biology, biomarkers, non-coding RNAs, soft tissue sarcomas, lung cancer, ovarian cancer.
Murali Yallapu
Department of Immunology and Microbiology, University of Texas Rio Grande Valley, McAllen, TX, USA.
Research Interests: cancer therapy, drug resistance, nanotechnology, theranostics, biomarker.
Takahiro Yamauchi
Department of Hematology and Oncology, University of Fukui, Fukui, Japan.
Research Interests: hematologic malignancies, nucleoside analogs, tyrosine kinase inhibitors, bcl2 inhibitors, antibodies, DNA repair, pharmacology.
Dong-Hua Yang
New York College of Traditional Chinese Medicine, Mineola, NY, USA.
Research Interests: biomarker, pharmacology, multi-drug resistance, cancer biology, Chinese medicine, immunohistochemistry.
Nadia Zaffaroni
Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy.
Research Interests: telomerase, prostatic neoplasms, melanoma, cisplatin, apoptosis, neoplasms.
All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. OAE Publishing Inc. remains neutral with regard to any jurisdictional claims.
